Get startedLog in
    Picture of High Tech Pharm Co logo

    106190 — High Tech Pharm Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for High Tech Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-3,152-1,2254,0289,86417,087
    Depreciation
    Non-Cash Items1,5661,5922,2121,8981,981
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-11,5571,011-15,488-13,839-9,546
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-7,6916,928-3,7032,90914,691
    Capital Expenditures-937-860-656-5,091-2,133
    Purchase of Fixed Assets
    Other Investing Cash Flow Items6,952-4321,386-1,664990
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities6,015-1,292730-6,755-1,143
    Financing Cash Flow Items————194
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-3934,621-390-529-9,416
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-2,07110,237-3,394-4,3984,276